Participants 131 162 3
secondarily infected dermatitis
Participants 341 392 5
patients with secondarily infected dermatitis (SID)
Participants 552 569 9
Patients with SID
Participants 861 872 3
Retapamulin
Participants 893 903 3
cephalexin
Participants 1687 1695 5
patients
